Open AccessLenalidomide and Rituximab Maintenance Therapy after Front-Line Induction Chemoimmunotherapy in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Author(s) -
Julie Chang,
Vaishalee P. Kenkre,
Christopher D.�M. Fletcher,
Aric C. Hall,
Natalie S. Callander,
KyungMann Kim,
Yi Chen,
Kaitlin Chambers
Publication year - 2019
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood-2019-124489
Subject(s) - medicine , bendamustine , rituximab , lenalidomide , chemoimmunotherapy , maintenance therapy , neutropenia , chronic lymphocytic leukemia , chemotherapy , gastroenterology , surgery , progressive disease , oncology , urology , multiple myeloma , leukemia , lymphoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom